Oracea Soolantra Association in Participants With Severe Rosacea

Summary

The main objective of this study is to evaluate the efficacy of Ivermectin 1% topical cream associated with Doxycycline 40 mg Modified release (MR) capsules versus Ivermectin 1% topical cream associated with Placebo in the treatment of severe Rosacea.

Timeline

Start

2017-07-05

Primary completion

2018-02-08

Completion

2018-02-08

Outcome

Met primary endpoint

registry analysis (superiority test); Ivermectin 1% Cream + Doxycycline 40 mg MR Capsules vs Ivermectin 1% Cream + Oral Placebo Capsules; p = 0.032; Cochran-Mantel-Haenszel NCT03075891 ↗

Drugs

Indications